The International Congress of The Transplantation Society (TTS) is set to return to Sydney in 2026 for the third time.
This biennial meeting is the peak international transplant congress bringing together the world’s leaders in transplantation including researchers, clinicians, service providers and industry to collaborate on cutting-edge science, the latest clinical developments, ethics and public policy.
The congress is worth an estimated A$10.3 million (US$6.6 million) to the New South Wales economy and will see 3,000 global delegates in Sydney over four days at the International Convention Centre, Sydney.
Sydney is home to several research centres and groups, including the Garvan Institute of Medical Research, Victor Chang Cardiac Research Institute and The Charles Perkins Centre at The University of Sydney. NSW hosts national centres for paediatric liver transplantation, islet cell transplantation and pancreas transplantation and there were 320 organ transplant recipients in NSW in 2021.
TTS is an NGO that serves as an international focus for leadership in transplantation science, clinical care and ethics. With official relations with the World Health Organization, TTS comprises some 6,000 professionals including but not limited to, physicians, surgeons, scientists and allied health professionals across 105 countries.
The event is hosted by local association The Transplantation Society of Australia and New Zealand, and supported by BESydney, and Australia’s Business Events Bid Fund Program.
